- Home
- FMC vs ITGR Comparison
FMC vs ITGR Comparison
Compare FMC & ITGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FMC
- ITGR
- Stock Information
- Founded
- FMC 1910
- ITGR 1970
- Country
- FMC United States
- ITGR United States
- Employees
- FMC N/A
- ITGR N/A
- Industry
- FMC Major Chemicals
- ITGR Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- FMC Industrials
- ITGR Health Care
- Exchange
- FMC Nasdaq
- ITGR Nasdaq
- Market Cap
- FMC 4.8B
- ITGR 4.1B
- IPO Year
- FMC N/A
- ITGR 2000
- Fundamental
- Price
- FMC $36.79
- ITGR $118.42
- Analyst Decision
- FMC Hold
- ITGR Strong Buy
- Analyst Count
- FMC 13
- ITGR 10
- Target Price
- FMC $50.38
- ITGR $146.40
- AVG Volume (30 Days)
- FMC 1.9M
- ITGR 758.2K
- Earning Date
- FMC 04-30-2025
- ITGR 04-24-2025
- Dividend Yield
- FMC 6.30%
- ITGR N/A
- EPS Growth
- FMC N/A
- ITGR N/A
- EPS
- FMC 2.62
- ITGR 2.18
- Revenue
- FMC $4,119,500,000.00
- ITGR $1,746,192,000.00
- Revenue This Year
- FMC N/A
- ITGR $10.86
- Revenue Next Year
- FMC $6.58
- ITGR $7.15
- P/E Ratio
- FMC $14.07
- ITGR $54.77
- Revenue Growth
- FMC 1.45
- ITGR 10.19
- 52 Week Low
- FMC $32.83
- ITGR $104.93
- 52 Week High
- FMC $68.72
- ITGR $146.36
- Technical
- Relative Strength Index (RSI)
- FMC 42.91
- ITGR 46.82
- Support Level
- FMC $34.85
- ITGR $115.91
- Resistance Level
- FMC $37.09
- ITGR $121.58
- Average True Range (ATR)
- FMC 1.35
- ITGR 4.47
- MACD
- FMC -0.31
- ITGR -0.29
- Stochastic Oscillator
- FMC 26.22
- ITGR 28.03
About FMC FMC Corporation
FMC is a pure-play global crop protection company with a fairly balanced product portfolio across geographies and crop exposure. Through acquisitions, FMC is now one of the five largest patented crop protection companies and focuses on the development of new products, including biologicals, through its research and development pipeline.
About ITGR Integer Holdings Corporation
Integer Holdings Corp is a manufacturer of medical device components used by original equipment manufacturers in the medical industry. The company also develops batteries used in nonmedical applications in the energy, military, and environmental markets. The firm organizes itself into one segment and derives its revenues from three product lines: Cardio & Vascular, Cardiac Rhythm Management & Neuromodulation and Other Markets. The company earns more than half of its revenue in the United States.